Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

Regenix hair treatment is ineffective and considered a marketing scam, with no noticeable improvement in hair thickness or fullness. Users suggest avoiding it and saving money.

The user started oral minoxidil and finasteride in March and noticed significant hair density improvement by August, despite experiencing a shedding phase. They also take biotin and report no side effects except for more keratosis pilaris on their arms.

Choosing a hair transplant clinic can be overwhelming due to similar marketing tactics, so people often rely on patient results, surgeon experience, and effective communication with clinic coordinators to make their decision. Online forums and communities are also helpful resources for gathering information and recommendations.

Finasteride and Minoxidil have become more popular due to aggressive marketing by companies like Hims and Keeps, and the influence of the looks-maxxing trend. The fading fear of Finasteride side effects and the lack of new treatments have also contributed to their increased use.

Korean scientists developed a red light therapy that reduces a hair loss marker by 92%. Users discussed the benefits and drawbacks of natural sunlight versus red light caps for hair health, with some suggesting supplements for vitamin D.

The conversation is about skepticism towards a product marketed as a "DHT BLOCKER" for hair loss, with users suggesting it is a scam and recommending proven treatments like finasteride and minoxidil. Other suggestions include lifestyle changes like a healthy diet, exercise, and stress reduction.

The user has been using dutasteride and minoxidil since March 2023, showing significant hair regrowth but still prefers a buzz cut due to uneven growth. Some users discuss side effects like reduced libido, while others suggest additional treatments like microneedling or hair transplants.

The user started a hair loss treatment in March 2025 using finasteride, minoxidil, omega-3, biotin, a DHT-blocking multivitamin, and a derma roller, and is satisfied with the progress after four months. The community is impressed with the results, noting significant hair regrowth and improvement.

A 22-year-old male used topical Minoxidil twice daily from March to July, then once daily from August to December, along with biotin tablets and occasional dermastamping. The biotin dosage was 5mg daily.

Finasteride and minoxidil can be obtained cheaply through Mark Cuban's Cost Plus Drugs and Costco's Kirkland brand, respectively, costing about $7.53/month combined. Amazon's RXPass and virtual visits at Dr. B. offer additional savings.

A 26-year-old male has been using Minoxidil since 2024 and added Finasteride in March 2026, but after six months, he sees no significant hair regrowth. Users suggest waiting 12-18 months for results, considering Vitamin D3, and possibly trying Dutasteride.

The user has been using oral finasteride since February 2025 and added oral minoxidil in March 2026, noticing significant regrowth but is concerned about recent hairline thinning, possibly due to a shedding phase. They are considering adding dutasteride and eventually getting a hair transplant for long-term density improvement.

The user has been using 5mg Minoxidil and 0.5mg Dutasteride daily since March and is unsure about progress, but others see slight improvement. Suggestions include adding microneedling and possibly a hair transplant if results are unsatisfactory after a year.

Breezula shows promise in stabilizing hair loss and potentially promoting regrowth at the one-year mark, offering hope for those who can't tolerate 5AR inhibitors. Its local targeting of androgen receptors could be a significant advancement if it avoids systemic side effects.

A 33-year-old woman experienced significant hair loss and found relief using Mary Ruth’s liquid morning multivitamin + hair growth and Nioxin shampoo and conditioner. She noticed reduced shedding and longer hair growth after three months of use.

The user has been using finasteride for over a year and topical minoxidil since March, noticing small hairs but no significant regrowth. Suggestions include continuing the current treatment, considering microneedling, and possibly trying oral minoxidil for better results.

PP405 shows promise for hair growth with significant results after 4 weeks, but skepticism exists due to its unavailability. Some users are hopeful for its potential, while others express concerns about side effects and market release delays.

The user has been using Finasteride, Minoxidil, and Biotin for hair regrowth since March 2024, with slow but steady progress. Suggestions include becoming 100% consistent, considering RU58841, and exploring oral Minoxidil.

The conversation discusses why there are no FDA-approved NSAAs like RU58841 on the market, despite their potential superiority to 5AR inhibitors like finasteride. It explores the effectiveness of treatments like Minoxidil, finasteride, and RU58841 for hair loss.

The conversation discusses the uncertainty of the legitimacy of minoxidil products in the EU market and mentions baricitinib as an approved, but expensive alternative. A method to test for real minoxidil involves mixing it with bleach to see if it turns orange or brown.

Pelage Pharmaceuticals is starting Phase 3 trials for PP405 in September 2026, with potential market release by 2030. Users discuss various hair loss treatments like minoxidil, finasteride, RU58841, kx, breezula, and gt20029, expressing hope for future hair restoration.

A 30-year-old man started taking oral finasteride in November 2025 and added oral minoxidil in March 2026, leading to healthier and thicker hair in three months. He experienced minor side effects with minoxidil and is pleased with the results.

After quitting minoxidil 100 days ago, OP is experiencing significant hair shedding, which began a week after stopping and worsened in March. Suggestions include calming the scalp, ensuring adequate protein and iron intake, and consulting a doctor if shedding persists.

Scientists have successfully grown functional hair follicles in the lab, marking a significant advancement in hair regeneration research. A user shared their personal experience with hair loss treatments, including Minoxidil and Finasteride, and plans to share a detailed protocol for hair restoration.

GT20029 is a potential treatment for androgenetic alopecia, addressing the root cause by targeting androgen receptors, unlike Minoxidil or Finasteride. It is seen as a preventative measure rather than a regrowth agent, with hopes for market release soon.

Results for PP405 are expected next year, with concerns about its pricing and potential black market availability. Some users believe it may be slightly more effective than finasteride and dutasteride, and combining it with treatments like minoxidil and microneedling could be beneficial.

Kopexil (Aminexil) is not approved as a drug in the US and Europe because it is marketed as a cosmetic, which requires less testing and regulation. L'Oreal's 1.5% Aminexil is noted to reduce hair shedding, but its efficacy as a drug is not proven.

The user had a hair transplant in December 2024 and started using topical minoxidil and finasteride in March 2025, along with dermarolling and multivitamins. They are experiencing increased hair shedding and are questioning if it's the "dread shed" phase.

PP405 is a potential hair loss treatment showing promising early results, with hopes for market release by 2028, but skepticism remains due to inconclusive data and past disappointments with similar products. Current treatments like Minoxidil and Finasteride have side effects, leading some to anticipate PP405 as a safer alternative, though its effectiveness compared to placebo is debated.

Celebrities often use brand names like Propecia for finasteride due to brand recognition, marketing, and potential sponsorships. In contrast, the general public and online communities may use generic names, reflecting differences in cultural and healthcare practices.